- $22.26bn
- $22.71bn
- $982.02m
Guardant Health prelim Q4 revenue rises 39%, beats expectations
Brief: Guardant Health Q4 Total Revenue Of Approx $280 Million
U.S. STOCKS ON THE MOVE-Eli Lilly, Fossil, Papa John's
U.S. STOCKS ON THE MOV-Guardant Health, Tower Semiconductor, GlobalFoundries
Guardant Health rises after expanding blood test to track cancer therapy response faster
U.S. RESEARCH ROUNDUP-Doordash, Honeywell, Zscaler
Brief: New Study Validates Guardant Reveal Blood Test’s Effectiveness in Monitoring Chemotherapy Response
U.S. STOCKS ON THE MOVE-Targa Resources, Illumina, Alphabet
U.S. STOCKS ON THE MOVE-Bunge, O'Reilly Automotive, Targa Resources
U.S. STOCKS ON THE MOVE-Lemonade, New York Times, Johnson Controls
Guardant Health slides on $650 mln stock, convertible bonds sales
Brief: Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes Offering
Brief: Guardant Health Announces Proposed $300.0 Million Offering Of Convertible Senior Notes Due 2033
Guardant Health slides on stock, convertible bonds sale plans
U.S. RESEARCH ROUNDUP- Crowdstrike, Guardant Health, Palantir Technologies
U.S. RESEARCH ROUNDUP- Alphabet, Boeing, KLA
Guardant Health Q3 revenue up 39%, beats estimates
Brief: Guardant Health Q3 Adjusted EPS USD -0.39 Vs. IBES Estimate USD -0.76
Brief: Guardant Health And Zephyr Ai Announce Partnership To Unlock Drug Response Predictions And Biomarker Insights